Literature DB >> 23862723

Microparticles prepared from sulfenamide-based polymers.

Sheetal R D'Mello1, Jun Yoo, Ned B Bowden, Aliasger K Salem.   

Abstract

Polysulfenamides (PSN), with a SN linkage (RSNR2) along the polymer backbone, are a new class of biodegradable and biocompatible polymers. These polymers were unknown prior to 2012 when their synthesis and medicinally relevant properties were reported. The aim of this study was to develop microparticles as a controlled drug delivery system using polysulfenamide as the matrix material. The microparticles were prepared by a water-in-oil-in-water double-emulsion solvent-evaporation method. For producing drug-loaded particles, FITC-dextran was used as a model hydrophilic compound. At the optimal formulation conditions, the external morphology of the PSN microparticles was examined by scanning electron microscopy to show the formation of smooth-surfaced spherical particles with low polydispersity. The microparticles had a net negative surface charge (-23 mV) as analyzed by the zetasizer. The drug encapsulation efficiency of the particles and the drug loading were found to be dependent on the drug molecular weight, amount of FITC-dextran used in fabricating FITC-dextran-loaded microparticles, concentration of PSN and surfactant, and volume of the internal and external water phases. FITC-dextran was found to be distributed throughout the PSN microparticles and was released in an initial burst followed by more continuous release over time. Confocal laser scanning microscopy was used to qualitatively observe the cellular uptake of PSN microparticles and indicated localization of the particles in both the cytoplasm and the nucleus.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23862723      PMCID: PMC4295722          DOI: 10.3109/02652048.2013.814728

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  22 in total

1.  Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.

Authors:  Y Y Yang; T S Chung; N P Ng
Journal:  Biomaterials       Date:  2001-02       Impact factor: 12.479

2.  Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.

Authors:  Y Capan; B H Woo; S Gebrekidan; S Ahmed; P P DeLuca
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

3.  Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.

Authors:  Juan Wang; Barbara M Wang; Steven P Schwendeman
Journal:  Biomaterials       Date:  2004-05       Impact factor: 12.479

4.  (D, L) polylactide microspheres as embolic agent. A preliminary study.

Authors:  P Flandroy; C Grandfils; J Collignon; A Thibaut; N Nihant; S Barbette; R Jerome; P Teyssie
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

5.  Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.

Authors:  Shirui Mao; Jing Xu; Cuifang Cai; Oliver Germershaus; Andreas Schaper; Thomas Kissel
Journal:  Int J Pharm       Date:  2006-10-28       Impact factor: 5.875

6.  Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.

Authors:  S Prior; C Gamazo; J M Irache; H P Merkle; B Gander
Journal:  Int J Pharm       Date:  2000-02-25       Impact factor: 5.875

7.  Vancomycin biodegradable poly(lactide-co-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading and in vitro release.

Authors:  A Billon; L Chabaud; A Gouyette; J-M Bouler; C Merle
Journal:  J Microencapsul       Date:  2005-12       Impact factor: 3.142

8.  Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.

Authors:  Gang Ruan; Si-Shen Feng
Journal:  Biomaterials       Date:  2003-12       Impact factor: 12.479

9.  Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods.

Authors:  Sergio Galindo-Rodriguez; Eric Allémann; Hatem Fessi; Eric Doelker
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

10.  PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency.

Authors:  Xiangrong Song; Yu Zhao; Wenbin Wu; Yueqi Bi; Zheng Cai; Qiuhong Chen; Yuanbo Li; Shixiang Hou
Journal:  Int J Pharm       Date:  2007-08-30       Impact factor: 5.875

View more
  3 in total

1.  Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.

Authors:  Sean M Geary; Qiaohong Hu; Vijaya B Joshi; Ned B Bowden; Aliasger K Salem
Journal:  J Control Release       Date:  2015-09-08       Impact factor: 9.776

2.  A Pilot Study Evaluating Combinatorial and Simultaneous Delivery of Polyethylenimine-Plasmid DNA Complexes Encoding for VEGF and PDGF for Bone Regeneration in Calvarial Bone Defects.

Authors:  Sheetal R D'Mello; Satheesh Elangovan; Liu Hong; Ryan D Ross; D Rick Sumner; Aliasger K Salem
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.829

Review 3.  Applications of Nanovaccines for Disease Prevention in Cattle.

Authors:  Teresia W Maina; Elizabeth A Grego; Paola M Boggiatto; Randy E Sacco; Balaji Narasimhan; Jodi L McGill
Journal:  Front Bioeng Biotechnol       Date:  2020-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.